Sickle CHARTA is working with researchers, health care providers, patient advocates to promote, strengthen and build partnerships to develop advanced therapy for Sickle Cell Disease in Africa. CHARTA - Coordination, Health, Advocacy, Research, Training in Africa. E: sicklecharta@blood.ac.tz
Company Details
- Founded
- -
- Address
- Dar Es Salaam, Dar Es Salaam 000000, Tz
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- Dar es Salaam.
- HQ
- Dar es Salaam, Dar es Salaam
- Competitors
- Science Summit 2025, SynGAP Research Fund (SRF) for SYNGAP1-Related Disorders, MUHAS INTERNATIONAL OFFICE, Freeman Hospital, Global Blood Fund, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, EQuity Lab, The Matilda Centre for Research in Mental Health and Substance Use, Muhimbili University of Health and Allied Sciences (MUHAS), McGill Global Health Programs | Programmes de santé mondiale.
Sickle Charta Questions
Sickle Charta's LinkedIn profile is https://tz.linkedin.com/company/sickle-charta
Sickle Charta's industry is
Research Services
Sickle Charta's top competitors are
Science Summit 2025,
Syngap Research Fund (Srf) For Syngap1-Related Disorders,
Muhas International Office,
Freeman Hospital,
Global Blood Fund,
The Newcastle Upon Tyne Hospitals Nhs Foundation Trust,
Equity Lab,
The Matilda Centre For Research In Mental Health And Substance Use,
Muhimbili University Of Health And Allied Sciences (Muhas),
Mcgill Global Health Programs | Programmes De Santé Mondiale.
Sickle Charta's categories are Research Services
Sickle Charta's founding year is 2021
